|
|
Property / knows about | |
| | |
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / rank | |
| Normal rank
| |
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / qualifier | |
| | |
Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / rank | |
| Normal rank
| |
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / qualifier | |
| | |
Property / knows about: Epidemiology and Treatment of Childhood Leukemia / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Acute Myeloid Leukemia / rank | |
| Normal rank
| |
Property / knows about: Acute Myeloid Leukemia / qualifier | |
| | |
Property / knows about: Acute Myeloid Leukemia / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / rank | |
| Normal rank
| |
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / qualifier | |
| | |
Property / knows about: Management of Febrile Neutropenia in Cancer Patients / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / rank | |
| Normal rank
| |
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / qualifier | |
| | |
Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / rank | |
| Normal rank
| |
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / qualifier | |
| | |
Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Gene Therapy Techniques and Applications / rank | |
| Normal rank
| |
Property / knows about: Gene Therapy Techniques and Applications / qualifier | |
| | |
Property / knows about: Gene Therapy Techniques and Applications / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Pediatric Cancer and Quality of Life / rank | |
| Normal rank
| |
Property / knows about: Pediatric Cancer and Quality of Life / qualifier | |
| | |
Property / knows about: Pediatric Cancer and Quality of Life / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Lymphoid Neoplasms / rank | |
| Normal rank
| |
Property / knows about: Lymphoid Neoplasms / qualifier | |
| | |
Property / knows about: Lymphoid Neoplasms / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Advancements in Lung Cancer Research / rank | |
| Normal rank
| |
Property / knows about: Advancements in Lung Cancer Research / qualifier | |
| | |
Property / knows about: Advancements in Lung Cancer Research / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Molecular Research on Breast Cancer / rank | |
| Normal rank
| |
Property / knows about: Molecular Research on Breast Cancer / qualifier | |
| | |
Property / knows about: Molecular Research on Breast Cancer / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Cardiotoxicity of Cancer Treatments / rank | |
| Normal rank
| |
Property / knows about: Cardiotoxicity of Cancer Treatments / qualifier | |
| | |
Property / knows about: Cardiotoxicity of Cancer Treatments / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Efficacy and Resistance in CML Treatment / rank | |
| Normal rank
| |
Property / knows about: Efficacy and Resistance in CML Treatment / qualifier | |
| | |
Property / knows about: Efficacy and Resistance in CML Treatment / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Immunobiology of Dendritic Cells / rank | |
| Normal rank
| |
Property / knows about: Immunobiology of Dendritic Cells / qualifier | |
| | |
Property / knows about: Immunobiology of Dendritic Cells / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / rank | |
| Normal rank
| |
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / qualifier | |
| | |
Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Expanding Access to Radiotherapy Globally / rank | |
| Normal rank
| |
Property / knows about: Expanding Access to Radiotherapy Globally / qualifier | |
| | |
Property / knows about: Expanding Access to Radiotherapy Globally / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Small Cell Lung Cancer / rank | |
| Normal rank
| |
Property / knows about: Small Cell Lung Cancer / qualifier | |
| | |
Property / knows about: Small Cell Lung Cancer / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Globalization of Law and Legal Methodology / rank | |
| Normal rank
| |
Property / knows about: Globalization of Law and Legal Methodology / qualifier | |
| | |
Property / knows about: Globalization of Law and Legal Methodology / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / rank | |
| Normal rank
| |
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / qualifier | |
| | |
Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Natural Killer Cells in Immunity / rank | |
| Normal rank
| |
Property / knows about: Natural Killer Cells in Immunity / qualifier | |
| | |
Property / knows about: Natural Killer Cells in Immunity / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Hematopoietic Stem Cell Biology / rank | |
| Normal rank
| |
Property / knows about: Hematopoietic Stem Cell Biology / qualifier | |
| | |
Property / knows about: Hematopoietic Stem Cell Biology / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: The p53 Signaling Network in Cancer Research / rank | |
| Normal rank
| |
Property / knows about: The p53 Signaling Network in Cancer Research / qualifier | |
| | |
Property / knows about: The p53 Signaling Network in Cancer Research / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / rank | |
| Normal rank
| |
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / qualifier | |
| | |
Property / knows about: Mechanisms of Multidrug Resistance in Cancer / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / rank | |
| Normal rank
| |
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / qualifier | |
| | |
Property / knows about: Diagnosis and Treatment of Multiple Myeloma / reference | |
| | |
Property / knows about | |
| | |
Property / knows about: Neuroblastoma Research and Treatment / rank | |
| Normal rank
| |
Property / knows about: Neuroblastoma Research and Treatment / qualifier | |
| | |
Property / knows about: Neuroblastoma Research and Treatment / reference | |
| | |
| Property / knows about |
| | |
| Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / rank |
| | Normal rank |
| Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / qualifier |
| | |
| Property / knows about: Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Epidemiology and Treatment of Childhood Leukemia / rank |
| | Normal rank |
| Property / knows about: Epidemiology and Treatment of Childhood Leukemia / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Epidemiology and Treatment of Childhood Leukemia / qualifier |
| | |
| Property / knows about: Epidemiology and Treatment of Childhood Leukemia / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Acute Myeloid Leukemia / rank |
| | Normal rank |
| Property / knows about: Acute Myeloid Leukemia / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Acute Myeloid Leukemia / qualifier |
| | |
| Property / knows about: Acute Myeloid Leukemia / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Management of Febrile Neutropenia in Cancer Patients / rank |
| | Normal rank |
| Property / knows about: Management of Febrile Neutropenia in Cancer Patients / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Management of Febrile Neutropenia in Cancer Patients / qualifier |
| | |
| Property / knows about: Management of Febrile Neutropenia in Cancer Patients / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / rank |
| | Normal rank |
| Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / qualifier |
| | |
| Property / knows about: Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / rank |
| | Normal rank |
| Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / qualifier |
| | |
| Property / knows about: DNA Topoisomerases: Structure, Function, and Inhibition / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Gene Therapy Techniques and Applications / rank |
| | Normal rank |
| Property / knows about: Gene Therapy Techniques and Applications / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Gene Therapy Techniques and Applications / qualifier |
| | |
| Property / knows about: Gene Therapy Techniques and Applications / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Pediatric Cancer and Quality of Life / rank |
| | Normal rank |
| Property / knows about: Pediatric Cancer and Quality of Life / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Pediatric Cancer and Quality of Life / qualifier |
| | |
| Property / knows about: Pediatric Cancer and Quality of Life / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Lymphoid Neoplasms / rank |
| | Normal rank |
| Property / knows about: Lymphoid Neoplasms / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Lymphoid Neoplasms / qualifier |
| | |
| Property / knows about: Lymphoid Neoplasms / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Advancements in Lung Cancer Research / rank |
| | Normal rank |
| Property / knows about: Advancements in Lung Cancer Research / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Advancements in Lung Cancer Research / qualifier |
| | |
| Property / knows about: Advancements in Lung Cancer Research / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Molecular Research on Breast Cancer / rank |
| | Normal rank |
| Property / knows about: Molecular Research on Breast Cancer / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Molecular Research on Breast Cancer / qualifier |
| | |
| Property / knows about: Molecular Research on Breast Cancer / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Cardiotoxicity of Cancer Treatments / rank |
| | Normal rank |
| Property / knows about: Cardiotoxicity of Cancer Treatments / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Cardiotoxicity of Cancer Treatments / qualifier |
| | |
| Property / knows about: Cardiotoxicity of Cancer Treatments / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Efficacy and Resistance in CML Treatment / rank |
| | Normal rank |
| Property / knows about: Efficacy and Resistance in CML Treatment / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Efficacy and Resistance in CML Treatment / qualifier |
| | |
| Property / knows about: Efficacy and Resistance in CML Treatment / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Immunobiology of Dendritic Cells / rank |
| | Normal rank |
| Property / knows about: Immunobiology of Dendritic Cells / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Immunobiology of Dendritic Cells / qualifier |
| | |
| Property / knows about: Immunobiology of Dendritic Cells / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / rank |
| | Normal rank |
| Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / qualifier |
| | |
| Property / knows about: Genomic Studies and Treatment of Ovarian Carcinoma / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Expanding Access to Radiotherapy Globally / rank |
| | Normal rank |
| Property / knows about: Expanding Access to Radiotherapy Globally / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Expanding Access to Radiotherapy Globally / qualifier |
| | |
| Property / knows about: Expanding Access to Radiotherapy Globally / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Small Cell Lung Cancer / rank |
| | Normal rank |
| Property / knows about: Small Cell Lung Cancer / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Small Cell Lung Cancer / qualifier |
| | |
| Property / knows about: Small Cell Lung Cancer / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Globalization of Law and Legal Methodology / rank |
| | Normal rank |
| Property / knows about: Globalization of Law and Legal Methodology / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Globalization of Law and Legal Methodology / qualifier |
| | |
| Property / knows about: Globalization of Law and Legal Methodology / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / rank |
| | Normal rank |
| Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / qualifier |
| | |
| Property / knows about: Genomic Landscape of Cancer and Mutational Signatures / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Natural Killer Cells in Immunity / rank |
| | Normal rank |
| Property / knows about: Natural Killer Cells in Immunity / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Natural Killer Cells in Immunity / qualifier |
| | |
| Property / knows about: Natural Killer Cells in Immunity / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Hematopoietic Stem Cell Biology / rank |
| | Normal rank |
| Property / knows about: Hematopoietic Stem Cell Biology / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Hematopoietic Stem Cell Biology / qualifier |
| | |
| Property / knows about: Hematopoietic Stem Cell Biology / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: The p53 Signaling Network in Cancer Research / rank |
| | Normal rank |
| Property / knows about: The p53 Signaling Network in Cancer Research / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: The p53 Signaling Network in Cancer Research / qualifier |
| | |
| Property / knows about: The p53 Signaling Network in Cancer Research / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Mechanisms of Multidrug Resistance in Cancer / rank |
| | Normal rank |
| Property / knows about: Mechanisms of Multidrug Resistance in Cancer / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Mechanisms of Multidrug Resistance in Cancer / qualifier |
| | |
| Property / knows about: Mechanisms of Multidrug Resistance in Cancer / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Diagnosis and Treatment of Multiple Myeloma / rank |
| | Normal rank |
| Property / knows about: Diagnosis and Treatment of Multiple Myeloma / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Diagnosis and Treatment of Multiple Myeloma / qualifier |
| | |
| Property / knows about: Diagnosis and Treatment of Multiple Myeloma / reference |
| | |
| Property / knows about |
| | |
| Property / knows about: Neuroblastoma Research and Treatment / rank |
| | Normal rank |
| Property / knows about: Neuroblastoma Research and Treatment / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / knows about: Neuroblastoma Research and Treatment / qualifier |
| | |
| Property / knows about: Neuroblastoma Research and Treatment / reference |
| | |
| Property / OpenAlex ID |
| | |
| Property / OpenAlex ID: A5072965952 / rank |
| | Normal rank |
| Property / OpenAlex ID: A5072965952 / qualifier |
| | last update: 22 August 2024Timestamp | +2024-08-22T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / OpenAlex ID: A5072965952 / qualifier |
| | retrieved: 29 August 2024Timestamp | +2024-08-29T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|